Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildeno: Sildenafil + iNO for PPHN
NCT01558466Phase 3Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- Nov 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Hamad Medical Corporation. Status: unknown.
02
Drugs
ASP-001
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT01558466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01558466.